XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 102 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,483 | -29.0% | 24,991 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $65,476 | +60.7% | 24,991 | 0.0% | 0.00% | +33.3% |
Q1 2023 | $40,735 | +22.6% | 24,991 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $33,238 | -46.4% | 24,991 | -37.3% | 0.00% | -33.3% |
Q3 2022 | $62,000 | -40.4% | 39,831 | -40.8% | 0.00% | -25.0% |
Q2 2022 | $104,000 | -39.5% | 67,334 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $172,000 | -18.9% | 67,334 | -6.9% | 0.01% | -14.3% |
Q4 2021 | $212,000 | – | 72,334 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |